Search Results
150 items found for "Confo Therapeutics"
- GPCR Retreat 2023 - Part I
protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics
- Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia
To explore the therapeutic potential of GPR132 signaling, we screened and validated a natural product
- Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer
mechanisms of G-protein activation dysregulated in disease, these findings warrant the exploration of therapeutic
- Ep 113 with Dr. Prasenjit Saha
receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic
- Ep 148 with Dr Arthur Christopoulos
Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics
- The landscape of cancer-rewired GPCR signaling axes
G-protein-coupled receptor (GPCR) ligand systems in cancer transcriptomics datasets to uncover new therapeutics
- Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach
We suggest that SST2 and SST3 should be further explored as potential biomarkers and therapeutic tools
- Ep 149 with Dr Arthur Christopoulos
Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics
- Ep 113 with Dr. Prasenjit Saha
receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic
- GPR56 signaling pathway network and its dynamics in the mesenchymal transition of glioblastoma
heterogeneously in glioblastoma (GBM) and is involved in the mesenchymal transition, making it a promising therapeutic
- Distinct sub-cellular signal propagation as a component of functional selectivity
of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics
- Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling
Therefore, these antagonists may aid in the development of novel cancer therapeutics and patient-based
- Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration
interplay between CXCR4 and HRH1, and suggest the possibility of the CXCR4-HRH1 heteromer as a potential therapeutic
- Ep 36 with Dr. Michel Bouvier
of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics
- 20-08 Dr GPCR Newsletter
of the month Chemical biology of noncanonical G protein-coupled receptor signaling: Toward advanced therapeutics Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective Intrinsic efficacy of opioid ligands and its importance for apparent bias, operational analysis, and therapeutic
- 22-02 Dr GPCR Newsletter
Lipopeptide Pepducins as Therapeutic Agents. Heptares reported its FY2021 financial results and provided an update on operational activities Ermium Therapeutics Keystone Symposia in-person meeting- GPCRs: An Odyssey from Structure, Signaling, and Regulation to Therapeutics
- Ep 36 with Dr. Michel Bouvier
of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics
- Systems Pharmacodynamic Model of Combination Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways
pancreatic adenocarcinoma (PDAC) continues to present a formidable clinical challenge, demanding innovative therapeutic
- GPR15 expressed in T lymphocytes from RA patients is involved in leukocyte chemotaxis to the synovium
Our results suggest that GPR15/GPR15L have a pathogenic role in RA and their antagonizing could be a therapeutic
- Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone
targeting the Gs-GPCR or components of the downstream signaling pathway could serve as a promising therapeutic
- G protein-coupled receptors: A target for microbial metabolites and a mechanistic link to microbiome-immune-brain interactions
an improved understanding of gut microbiota-immune-brain molecular interactions and their potential therapeutic
- TIPE proteins control directed migration of human T cells by directing GPCR and lipid second messenger signaling
These findings have implications for therapeutically targeting TIPE proteins in human inflammatory and
- Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma
mediator in the advancement of OSCC, offering a potential avenue for the development of innovative therapeutic
- The orphan G protein-coupled receptor 141 expressed in myeloid cells functions as an inflammation suppressor
controlling the functions of monocytes and dendritic cells and that targeting GPR141 may be a possible therapeutic
- Activation of PI3K/Akt pathway by G protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell lung cancer
Therefore, our findings demonstrated that GPR37 may represent a viable therapeutic target for NSCLC."
- Interplay between G protein-coupled receptors and nanotechnology
understanding of the designated value of GPCRs for molecular engineering of biomaterials with GPCRs in therapeutical
- Investigating isoform switching in RHBDF2 and its role in neoplastic growth in breast cancer
In the past, studies predicting therapeutic drug targets for cancer therapy focused on the assumption
- G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer cells
Using co-immunoprecipitation, confocal immunofluorescence microscopy, and bioluminescence resonance energy